Evidence map›Paper›PMID 28926118›Full record

ArticleHepatology (Baltimore, Md.)2018

C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.

Runping Liu, Xiaojiaoyang Li, Zhiming Huang, Derrick Zhao, Bhagyalaxmi Sukka Ganesh, Guanhua Lai, William M Pandak, Phillip B Hylemon, Jasmohan S Bajaj, Arun J Sanyal and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 70 citations in OpenAlex.

  1. Gut microbes
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Runping LiuDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
Xiaojiaoyang LiDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
Zhiming HuangDepartment of Gastroenterology, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Derrick ZhaoDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
Bhagyalaxmi Sukka GaneshDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
Guanhua LaiDepartment of Pathology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
William M PandakMcGuire Veterans Affairs Medical Center, Virginia Commonwealth University, Richmond, VA.
Phillip B HylemonDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.
Jasmohan S BajajMcGuire Veterans Affairs Medical Center, Virginia Commonwealth University, Richmond, VA.
Arun J SanyalDepartment of Internal Medicine/GI Division, Virginia Commonwealth University, Richmond, VA.
Huiping ZhouDepartment of Microbiology and Immunology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA.ORCID 0000-0002-0050-372X
Virginia Commonwealth University · USVirginia Commonwealth University Medical Center · USWenzhou Medical University · CN

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · 1985 to 2026
$51.0M
Regulation of Hepatic SphK2 by Bile Acids: Effects on Lipid MetabolismR01DK057543 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2001 to 2015
$4.4M
LncRNA H19 in Cholestatic Liver DiseasesR01DK115377 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2018 to 2021
$2.1M
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in CholestasisR01DK104893 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI HYLEMON, PHILLIP B, ZHOU, HUIPING ROSE · 2016 to 2020
$2.0M
BLRD VA I01 BX000197BLRD VA I01 BX001390BLRD VA I01 BX004033BLRD VA IK6 BX004477CSRD VA I01 CX001076NCI NIH HHS P30 CA016059NIDDK NIH HHS R01 DK057543NIDDK NIH HHS R01 DK104893NIDDK NIH HHS R01 DK115377
6 · The paper itself

Abstract

Impaired intestinal barrier function promotes the progression of various liver diseases, including cholestatic liver diseases. The close association of primary sclerosing cholangitis (PSC) with inflammatory bowel disease highlights the importance of the gut-liver axis. It has been reported that bile duct ligation (BDL)-induced liver fibrosis is significantly reduced in C/EBP homologous protein knockout (CHOP

conclusionActivation of ER stress and subsequent loss of stemness of ISCs plays a critical role in BDL-induced systemic inflammation and cholestatic liver injury. Modulation of the ER stress response represents a potential therapeutic strategy for cholestatic liver diseases as well as other inflammatory diseases. (Hepatology 2018;67:1441-1457).

Indexed as

AnimalsApoptosisBile DuctsCell Culture TechniquesCholestasisEndoplasmic Reticulum StressFemaleHepatocytesHumansIntestinal MucosaLigationLiverLiver DiseasesMaleMiceMice, Inbred C57BLTranscription Factor CHOP

Identifiers

PMID28926118
PMCPMC5859257
OpenAlexW2755407398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.